<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30238533</PMID>        <DateRevised>            <Year>2018</Year>            <Month>09</Month>            <Day>21</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1522-2586</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>20</Day>                    </PubDate>                </JournalIssue>                <Title>Journal of magnetic resonance imaging : JMRI</Title>                <ISOAbbreviation>J Magn Reson Imaging</ISOAbbreviation>            </Journal>            <ArticleTitle>Intravoxel Incoherent Motion Diffusion-Weighted MRI of Invasive Breast Cancer: Correlation With Prognostic Factors and Kinetic Features Acquired With Computer-Aided Diagnosis.</ArticleTitle>            <ELocationID EIdType="doi" ValidYN="Y">10.1002/jmri.26221</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">As both intravoxel incoherent motion (IVIM) modeling and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) provide perfusion parameters, IVIM-derived perfusion parameters might be expected to correlate with the kinetic features from DCE-MRI.</AbstractText>                <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">To investigate the association between IVIM parameters and prognostic factors and to evaluate the correlation between IVIM parameters and kinetic features in invasive breast cancer patients using computer-aided diagnosis (CAD).</AbstractText>                <AbstractText Label="STUDY TYPE" NlmCategory="METHODS">Retrospective.</AbstractText>                <AbstractText Label="POPULATION" NlmCategory="METHODS">Eighty-five patients (invasive cancers; mean size, 1.8 cm; range, 0.8-4.8 cm) who underwent diffusion-weighted imaging with 12 b-values (0-1000 s/mm<sup>2</sup> ).</AbstractText>                <AbstractText Label="FIELD STRENGTH/SEQUENCE" NlmCategory="UNASSIGNED">3.0T MRI axial, IVIM-DWI epi-sequence, and DCE-MRI.</AbstractText>                <AbstractText Label="ASSESSMENT" NlmCategory="RESULTS">Two radiologists measured the apparent diffusion coefficient (ADC), diffusion coefficient, pseudodiffusion coefficient, and perfusion fraction (f) using IVIM modeling. Kinetic features such as peak enhancement and early and delayed enhancement profiles were acquired using CAD.</AbstractText>                <AbstractText Label="STATISTICAL TESTS" NlmCategory="UNASSIGNED">The correlation between the IVIM parameters and kinetic features and the association between the IVIM parameters and prognostic factors were investigated using Mann-Whitney test and Spearman correlation test.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">There were no significant associations between IVIM parameters and prognostic factors. When IVIM parameters were correlated with kinetic features by CAD, both the ADC and f values showed correlations with delayed enhancement profiles. The ADC values were lower in tumors with lower persistent components (P = 0.013) and higher washout components (P = 0.045) and showed a positive correlation with persistent proportion (Spearman's rho (r) = 0.222, P = 0.041). The f value was higher in tumors with higher persistent components (P = 0.021) and showed a positive correlation with persistent proportion (r = 0.227, P = 0.029).</AbstractText>                <AbstractText Label="DATA CONCLUSION" NlmCategory="UNASSIGNED">This analysis revealed that IVIM-derived ADC and f values showed correlations with kinetic features at the delayed phase as assessed by CAD. These results indicate the potential of IVIM imaging biomarkers to provide information on the biological and kinetic properties of breast cancers without a contrast agent.</AbstractText>                <AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">4 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018.</AbstractText>                <CopyrightInformation>© 2018 International Society for Magnetic Resonance in Medicine.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Song</LastName>                    <ForeName>Sung Eun</ForeName>                    <Initials>SE</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cho</LastName>                    <ForeName>Kyu Ran</ForeName>                    <Initials>KR</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Seo</LastName>                    <ForeName>Bo Kyoung</ForeName>                    <Initials>BK</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Woo</LastName>                    <ForeName>Ok Hee</ForeName>                    <Initials>OH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Park</LastName>                    <ForeName>Kyong Hwa</ForeName>                    <Initials>KH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Oncology, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Son</LastName>                    <ForeName>Yo Han</ForeName>                    <Initials>YH</Initials>                    <AffiliationInfo>                        <Affiliation>Siemens Healthcare, Seoul, Korea.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Grimm</LastName>                    <ForeName>Robert</ForeName>                    <Initials>R</Initials>                    <AffiliationInfo>                        <Affiliation>Siemens Healthcare, Erlangen, Germany.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <Agency>Korea University</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>20</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>J Magn Reson Imaging</MedlineTA>            <NlmUniqueID>9105850</NlmUniqueID>            <ISSNLinking>1053-1807</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">breast neoplasm</Keyword>            <Keyword MajorTopicYN="N">diffusion magnetic resonance imaging</Keyword>            <Keyword MajorTopicYN="N">perfusion</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>18</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>05</Month>                <Day>24</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>22</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>22</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>22</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30238533</ArticleId>            <ArticleId IdType="doi">10.1002/jmri.26221</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>